About 300 reports

Report Scope: The global immunotherapy market can be segmented into the following types: checkpoint inhibitors, monoclonal antibodies, interferons and interleukins. This report does not include other immunotherapies such as vaccines and hormones. The scope of the report includes an overview of the global market and...

  • Immunotherapy
  • Monoclonal Antibody
  • World

Abstract: - Global Allergy Immunotherapy Market to Reach $3.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Allergy Immunotherapy estimated at US$1.7 Billion in the year 2020, is projected to reach a revised size of US$3.2 Billion by 2027, growing at aCAGR of 9.3% over the period 2020-2027. Subcutaneous...

  • Allergy Immunotherapy
  • World
  • China
  • United States

Abstract: - Global Immunotherapy Drugs Market to Reach $361.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Immunotherapy Drugs estimated at US$154.9 Billion in the year 2020, is projected to reach a revised size of US$361.6 Billion by 2027, growing at a CAGR of 12.9% over the analysis period 2020-2027....

  • Infectious Disease
  • Immunotherapy
  • World
  • China
  • United States

OTHER IMMUNOTHERAPIES

  • Immunotherapy
  • APAC
  • Indiana
  • Cancer Incidence
  • Drug Approval

Figure ##. Allergy Immunotherapies Market Segmentation

  • Allergy Immunotherapy
  • APAC
  • Allergy Prevalence
  • Processed Food Consumption

Allergy immunotherapies market

  • Allergy Immunotherapy
  • North America
  • Drug Approval
  • Allergy Prevalence

Figure ##. Allergy Immunotherapies Market Segmentation

  • Allergy Immunotherapy
  • Middle East
  • Africa
  • Allergy Prevalence
  • Drug Approval

Figure ##. Europe Allergy Immunotherapies Market Segmentation

  • Allergy Immunotherapy
  • Europe
  • Health Expenditure
  • Allergy Prevalence

Allergy Immunotherapies Market

  • Allergy Immunotherapy
  • APAC
  • World
  • Allergy Prevalence
  • Drug Approval

Allergy Immunotherapy Market Report Overview Allergy Immunotherapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Allergy Immunotherapy market types and applications. It is a focused study on Allergy Immunotherapy market space including...

  • Allergy Immunotherapy
  • World
  • Health Provider Density

Immunotherapy Drugs Market Report Overview Immunotherapy Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Immunotherapy Drugs market types and applications. It is a focused study on Immunotherapy Drugs market space including global...

  • Immunotherapy
  • World
  • Health Provider Density

The global allergy immunotherapies market reached a value of US$ 2.3 Billion in 2020. Allergy immunotherapy, also known as desensitization or hypo-sensitization, is a preventive medical treatment for allergic reactions to allergens including various foods, drugs, bee venom, grass pollens and house dust mites. It alters the immune system’s...

  • Allergy Immunotherapy
  • World
  • Allergy Prevalence
  • Health Expenditure

‘ICOS-Next Generation Immunotherapy—Competitive Landscape and Market Forecast–2035’ report delivers an in-depth understanding of the ICOS as well as the market trends of ICOS-Next Generation Immunotherapy in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report provides the upcoming drugs,...

  • Immunotherapy
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom

Oncolytic Virus Immunotherapy Market – Scope of the Report This report on the global oncolytic virus immunotherapy market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators of the market during the forecast period from 2020 to 2030.The report provides revenue of...

  • Immunotherapy
  • World

TYPE OF IMMUNOTHERAPY

  • Allergy Immunotherapy
  • Europe
  • APAC
  • Allergy Prevalence
  • Asthma Prevalence

‘LAG-3-Next Generation Immunotherapy—Competitive Landscape and Market Forecast–2035’ report delivers an in-depth understanding of the LAG-3 as well as the market trends of LAG-3-Next Generation Immunotherapy in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report provides the upcoming drugs,...

  • Immunotherapy
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

‘TIM-3-Next Generation Immunotherapy—Competitive Landscape and Market Forecast–2035’ report delivers an in-depth understanding of the TIM-3 as well as the market trends of TIM-3-Next Generation Immunotherapy in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. The report provides the upcoming drugs,...

  • Immunotherapy
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

There are numerous companies developing immunotherapy approaches to treat cancer, autoimmune and several other diseases.Current study describes some of the recent advances in immunotherapy, mostly cancer. These include refined cell therapies, stem cell applications in cancer treatment, monoclonal, polyclonal and bispecific antibodies.Some...

  • Immunotherapy
  • Artificial Intelligence
  • Cell Therapy
  • Oncology

Oncolytic Virus Immunotherapy Market – Scope of the Report The latest publication on the global oncolytic virus immunotherapy market evaluates opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global oncolytic virus immunotherapy market.The study offers...

  • Immunotherapy
  • World

Global Allergy Immunotherapies Market 2021-2025 The analyst has been monitoring the allergy immunotherapies market and it is poised to grow by $ 713.56 mn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Our report on allergy immunotherapies market provides a holistic analysis, market size...

  • Allergy Immunotherapy
  • World
  • Allergy Prevalence

Antibody Drug Conjugates (ADCs), Bispecific Monoclonal  Antibodies, Cancer Vaccines, Cytokines, Interferons, Chimeric  Antigen Receptor (CAR) T-Cell Therapy, PD-1/PD-L1 inhibitors,  Dendritic Cells, Checkpoint Inhibitors, Adopted Cell Therapy (ACT)  & IDO Inhibitors  Within...

  • Cancer Immunotherapy
  • Immunotherapy
  • Therapy
  • World

A new report published lends a holistic view of the global allergy immunotherapy market. This study provides an incisive look by analysing the restraints, opportunities, drivers, and pipeline products that could impact the growth of the allergy immunotherapy market. Market size has been analysed in the report in terms of revenue (US$ Mn)....

  • Allergy Immunotherapy
  • World

"Global Tumor Infiltrating Lymphocytes Immunotherapy Market Opportunity & Clinical Trials Insight 2025" Report Highlights: • Tumor Infiltrating Lymphocytes Immunotherapy Pipeline: 3 Therapies • Highest Phase of Development for Tumor Infiltrating Lymphocytes Immunotherapy : Phase II Trials • USA To Dominate...

  • Therapy
  • Immunotherapy
  • Oncology
  • World

BY IMMUNOTHERAPY

  • Allergy Drug
  • Food Allergy
  • Therapy
  • Allergy Immunotherapy
  • Europe
  • APAC
  • Africa
  • South Africa
  • Allergy Prevalence
  • Asthma Prevalence

INTRODUCTION According to the World Health Organization (WHO), cancer is considered to be among the second leading causes of mortality worldwide, accounting for an estimated 10 million deaths annually. In fact, the global cancer burden is anticipated to increase by 70% in the next 20 years, exerting tremendous physical,...

  • Immunotherapy
  • Therapy
  • World
  • APAC
  • Cause-Specific Mortality Rate

"Artificial Immune Modulation Therapy Market Opportunity & Clinical Trials Insight 2026" Report Highlights: • Immunotherapy Inspired Design for Artificial Immune Modulation (AIM) • Artificial Immune Modulations for Various Indications • Clinical Trial Insight for AIM: 3 Drugs  • Expected Price Range...

  • Therapy
  • Immunotherapy
  • World

Abstract: - Global Veterinary Oncology Market to Reach $400.2 Million by 2027 - Amid the COVID-19 crisis, the global market for Veterinary Oncology estimated at US$215.4 Million in the year 2020, is projected to reach a revised size of US$400.2 Million by 2027, growing at a CAGR of 9.3% over the analysis period 2020-2027....

  • Immunotherapy
  • Chemotherapy
  • Diagnostic Imaging
  • World
  • China
  • United States

Table ##a: Overview of Technology Companies with T-Cell and NK-Cell Engaging Bispecific Antibody Technologies

  • Immunotherapy
  • World
  • Prescription Drug Sales
  • Number Of Employees

INTRODUCTION The cancer therapeutics market is considered to be one of the most active segments within the pharmaceutical industry. In the past five years, the USFDA has approved more than 100 drugs for the treatment of different types of cancer. However, there is still a pressing need for more specific and potent drugs...

  • Immunotherapy
  • Therapy
  • World
  • APAC
  • Cancer Incidence

Immunotherapy Drugs Market by Type (Checkpoint Inhibitors [Brand {Humira, Rituxan/MabThera, Herceptin, Remicade, Enbrel}], Vaccines [Type {Preventive, Therapeutic}, Brand {Prevnar/Prevenar 13, Gardasil, ProQuad, Rotarix}]), by Therapy Area (Cancer, Autoimmune & Inflammatory Diseases, Infectious Diseases), by End User (Hospitals & Clinics,...

  • Immunotherapy
  • World
  • Chronic Disease Prevalence
  • Health Expenditure